Group 1 - The initial public offering (IPO) application of Moore Threads Technology (Beijing) Co., Ltd. has successfully passed the review by the Shanghai Stock Exchange Listing Review Committee [1] - The IPO application was officially reviewed on September 26, 2025, and received approval [2] - The company aims to raise 8 billion yuan through this IPO [2]

Core Points - The Shanghai Stock Exchange announced that Moore Threads plans to undergo review by the Sci-Tech Innovation Board on September 26 [1] - Several listed companies have responded regarding their cooperation with Moore Threads, indicating varying levels of investment and partnership [1][2] Group 1: Investment and Shareholding - Yuexiu Capital has identified Moore Threads as one of the investment projects of its industrial fund [1] - Xiamen Guomao holds a 0.67% stake in Moore Threads through an investment fund [1] - Wanhe Electric does not directly hold shares in Moore Threads but has a 0.4664% stake through a participating fund [1] - Heertai directly holds 1.0262% of Moore Threads [1] - Honglida indirectly holds approximately 0.3% of Moore Threads [1] - Chuling Information has an indirect holding of about 0.0229% in Moore Threads, which is minimal [1] Group 2: Business Cooperation - Zhuoyi Information has a client relationship with Moore Threads, but specific business cooperation details are confidential [1] - Kehua Data has initiated business cooperation with Moore Threads and other domestic GPU chip manufacturers [1] - Shenzhen Huqiang has established business cooperation with Moore Threads [1] Group 3: No Investment or Cooperation - Companies such as Juhua Technology, Jingxing Paper, and Sihui Tuxin have confirmed they do not hold shares in Moore Threads [2] - Many companies, including Dazhu CNC and Yiyaton, have stated they have no investment in Moore Threads [2] - Several companies, including Kabeiyi and Zhongke Chuangda, have reported no cooperation with Moore Threads [1][2]

Core Viewpoint - Baiaosaitu (Beijing) Pharmaceutical Technology Co., Ltd. is set to undergo its IPO review on September 24, 2025, after a two-year wait on the Sci-Tech Innovation Board, highlighting its progress in the biopharmaceutical sector and its innovative "Thousand Mice Ten Thousand Antibodies" program [1][4]. Group 1: Company Overview - Baiaosaitu was established in 2009 and operates as a preclinical CRO and biotechnology company, providing innovative animal models and drug development services based on its proprietary gene editing technology [1]. - The company has developed the RenMice platform, which allows for large-scale drug discovery targeting nearly a thousand potential drug targets [1]. Group 2: IPO Process and Financial Performance - The company was accepted for its Sci-Tech Innovation Board IPO on June 20, 2023, and has undergone two rounds of inquiries prior to the upcoming review [4]. - Financial data shows that Baiaosaitu's revenue increased from approximately 534 million yuan in 2022 to 980 million yuan in 2024, with a turnaround to a net profit of approximately 33.54 million yuan in 2024 after previous losses [5]. - In the first half of 2023, the company achieved a revenue of 621 million yuan, a 51.27% increase year-on-year, and reported a net profit of approximately 47.99 million yuan, indicating a successful recovery from losses [6]. Group 3: Research and Development Challenges - The company has experienced a significant reduction in its R&D personnel, with the number of dedicated R&D staff dropping from 58 in 2022 to just 5 in 2024, raising concerns about its innovation capacity [7]. - Governance issues are also present, as the major shareholders, who are a married couple, control over 27% of the voting rights, which may impact decision-making processes [7]. Group 4: Fundraising and Strategic Direction - Baiaosaitu has reduced its planned fundraising amount from 1.893 billion yuan to 1.185 billion yuan for its IPO, focusing on early drug development services, antibody drug research, and clinical projects [7][8]. - The company asserts that this reduction in fundraising will not alter its strategic direction, as the core projects will still revolve around its main business and technology platforms [8].

Core Viewpoint - The Shanghai Stock Exchange has decided to postpone the IPO review of Xiamen Youxun Chip Co., Ltd. on the Sci-Tech Innovation Board, raising concerns about the company's financial sustainability and governance issues [1] Group 1: Financial Concerns - The listing committee inquired about the risk of declining gross margins and the sustainability of the company's operating performance, focusing on product structure, pricing power, market expansion, major product validation, and existing orders [1] - The issuer is required to clarify whether there is a risk of continuous decline in gross margins and the sustainability of its operating performance [1] Group 2: Governance Issues - The committee questioned the existence of undisclosed related-party relationships or concerted action among certain investors, considering the low shareholding ratio of the actual controller and the short duration of control over the company [1] - Concerns were raised regarding the stability of the actual controller's control rights and the potential risk of control changes post-IPO due to historical shareholder disputes and multiple equity changes during the reporting period [1] Group 3: Accounting Compliance - The issuer must provide clarification on whether the accounting treatment of share-based payments during the reporting period complies with the relevant accounting standards [1] - The sponsor and reporting accountants are required to issue clear verification opinions on the accounting treatment [1]

Core Viewpoint - Xiamen Youxun Chip Co., Ltd. (referred to as "Youxun") has had its IPO on the Sci-Tech Innovation Board postponed for review, raising concerns about its financial sustainability and governance structure [1][2] Group 1: Company Overview - Youxun focuses on the research, design, and sales of optical communication front-end transceiver chips [1] - The company aims to raise approximately 809 million yuan for projects related to next-generation access networks, high-speed data center chips, automotive chips, and 800G and above optical communication chips [1] Group 2: IPO Review Concerns - The listing committee has requested Youxun to address potential risks related to declining gross margins, market expansion, and the sustainability of its operating performance [1] - The committee also inquired about undisclosed relationships among certain investors and the stability of the actual controller's control over the company, given the low shareholding ratio and historical disputes among shareholders [1] Group 3: Financial Reporting - Youxun is required to clarify whether its accounting treatment for share-based payments complies with the relevant accounting standards [2]

Core Viewpoint - The IPO review of Xiamen Youxun Chip Co., Ltd. has been suspended by the Shanghai Stock Exchange, raising concerns about the company's financial sustainability and control issues [1][2]. Group 1: Company Overview - Youxun Chip focuses on the research, design, and sales of optical communication front-end transceiver chips, with an initial fundraising target of 889 million yuan [2]. - The company was accepted for IPO review on June 26 and entered the inquiry phase on July 15, responding efficiently to two rounds of inquiries before reaching the review stage [2]. Group 2: Financial Concerns - Key issues raised during the review include the risk of declining gross margins, sustainability of operating performance, and the stability of the actual controller's control [2][3]. - The Shanghai Stock Exchange has requested the company to clarify whether there is a risk of continuous decline in gross margins and the sustainability of its operating performance, considering factors such as product structure and market development [2]. Group 3: Control Issues - The control structure of Youxun Chip is complex, with the actual controller holding a total of 27.13% of voting rights, raising questions about the stability of control and potential risks of changes post-IPO [4]. - The company has a dispersed shareholding structure, with 67.72% of natural and non-natural person shareholders committing not to seek control, combined with the actual controller's voting rights, totaling 94.85% [4].

Core Viewpoint - Xiamen Youxun Chip Co., Ltd. (referred to as "Youxun") has had its IPO on the Sci-Tech Innovation Board postponed for review, raising concerns about its financial sustainability and governance structure [1][2] Group 1: Company Overview - Youxun focuses on the research, design, and sales of optical communication front-end transceiver chips [1] - The company aims to raise approximately 809 million yuan for the development and industrialization of next-generation access network and high-speed data center chips, automotive chips, and 800G and above optical communication chips and silicon photonic components [1] Group 2: IPO Review Concerns - The listing committee has requested Youxun to address potential risks related to declining gross margins, market expansion, and the sustainability of its operating performance [1] - The committee also inquired about undisclosed related party relationships among certain investors and the stability of the actual controller's control over the company, given the low shareholding ratio and historical ownership changes [1] Group 3: Accounting Compliance - Youxun is required to clarify whether its accounting treatment of share-based payments during the reporting period complies with the relevant accounting standards [2]

Core Viewpoint - Xiamen Youxun Chip Co., Ltd. is seeking to list on the STAR Market, with its IPO application being reviewed on September 19, 2023, despite underperforming in revenue growth and profitability metrics compared to market expectations [1][3]. Company Overview - Established in February 2003, Youxun specializes in the research, design, and sales of optical communication front-end transceiver chips, focusing on optical modules including transceiver components, optical modules, and optical terminals [1]. - The company plans to raise 809 million yuan through its IPO, primarily for three projects: next-generation access network and high-speed data center chip development, automotive chip R&D, and 800G and above optical communication chip and silicon photonics component development [3]. Financial Performance - Youxun's revenue for 2022 to 2024 is projected at 339 million yuan, 313 million yuan, and 411 million yuan, respectively, with net profits of 81.4 million yuan, 72.1 million yuan, and 77.9 million yuan, indicating a lack of strong growth typically expected from a STAR Market company [3][4]. - The company's gross profit margin has shown a declining trend, with rates of 55.26%, 49.14%, 46.75%, and 43.48% over the reporting periods, raising concerns about its profitability stability [4]. Corporate Governance - The company has faced internal conflicts for over a decade, leading to a lack of a clear controlling shareholder until recently. The actual controllers, Ke Binglan and Ke Tenglong, hold a combined voting power of 27.13%, which will dilute to 20.35% post-IPO, potentially exposing the company to control risks [4]. - Concerns have been raised regarding the independence of the board, particularly with an independent director linked to Xiamen University, where the controlling shareholder previously worked [5]. Disclosure Issues - There are questions regarding the adequacy of information disclosure, particularly concerning the rental agreements for the Shanghai subsidiary and the background of the controlling shareholder's spouse, which were not fully detailed in the prospectus [5][6].

Group 1 - The core point of the article is that Changjin Photon Technology Co., Ltd. has entered the inquiry stage for its IPO on the Sci-Tech Innovation Board [1] - Changjin Photon is a manufacturer of specialty optical fibers, with capabilities in high-performance and multi-category specialty optical fiber research and industrialization [1] - The company aims to raise approximately 780 million yuan through the IPO, which will be used for the construction of a high-performance specialty optical fiber production base and research center, as well as to supplement working capital [1]

Group 1 - The core point of the article is that Xiamen Hengkang New Materials Technology Co., Ltd. has successfully registered its IPO on the Sci-Tech Innovation Board [1] - The company focuses on the research and industrial application of key materials in the integrated circuit field, specifically in the development, production, and sales of photoresist materials and precursor materials [1] - The IPO process began with acceptance on December 26, 2024, followed by an inquiry phase starting on January 18, 2025, and approval on August 29, 2025, with registration submitted on the same day [1] Group 2 - Hengkang New Materials aims to raise approximately 1.007 billion yuan through this IPO, which will be allocated to the second phase of the integrated circuit precursor project and advanced materials for integrated circuits, after deducting issuance costs [1]